Browsing by Author Biasi, Maria Olivia

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 3 of 3
Issue DateTitleAuthor(s)Citation
2015CYP19A1 polymorphisms and clinical outcomes in postmenopausal women with hormone receptor-positive breast cancer in the BIG 1-98 trialCoates, Alan; Abramovitz, Mark; Biasi, Maria Olivia; Bouzyk, Mark; Dell’Orto, Patrizia; et al, Various; Gray, Kathryn P; Kammler, Roswitha; Leyland-Jones, Brian; Long, Bradley; Thurlimann, B.; Young, Brandon; School of Public Health: Public HealthCYP19A1 polymorphisms and clinical outcomes in postmenopausal women with hormone receptor-positive breast cancer in the BIG 1-98 trial, Breast Cancer Research and Treatment, vol.151, 2, 2015,pp 373-384
2012CYP2D6 genotype and tamoxifen response in postmenopausal women with endocrine-responsive breast cancer: the breast international group 1-98 trialCoates, Alan; Biasi, Maria Olivia; Bouzyk, Mark; Dell’Orto, Patrizia; Ditzel, Henrik; et al, various; Kammler, Roswitha; Leyland-Jones, Brian; Lyng, Maria; Pagani, Olivia; Regan, Meredith M.; Tang, Weining; Thurlimann, Beat; School of Public Health: Public HealthCYP2D6 genotype and tamoxifen response in postmenopausal women with endocrine-responsive breast cancer: the breast international group 1-98 trial, Journal of the National Cancer Institute, vol.104, 6, 2012,pp 441-451
2015ESR1 and ESR2 polymorphisms in the BIG 1-98 trial comparing adjuvant letrozole versus tamoxifen or their sequence for early breast cancerCoates, Alan; Abramovitz, Mark; Biasi, Maria Olivia; Bouzyk, Mark; Dell’Orto, Patrizia; et al, Various; Gray, Kathryn P; Kammler, Roswitha; Leyland-Jones, Brian; Long, Bradley; Thurlimann, Beat; Young, Brandon; School of Public Health: Public HealthESR1 and ESR2 polymorphisms in the BIG 1-98 trial comparing adjuvant letrozole versus tamoxifen or their sequence for early breast cancer, Breast Cancer Research and Treatment, vol.154, 3, 2015,pp 543-555